Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells. | Front Cell Infect Microbiol | 2023 | 38162580 | PubTator, text mining | PubMed |
| Inhibitors of the Elastase LasB for the Treatment of Pseudomonas aeruginosa Lung Infections. | ACS Cent Sci | 2023 | 38161367 | PubTator, text mining | PubMed |
| A Review on Molecular Docking on HDAC Isoforms: Novel Tool for Designing Selective Inhibitors. | Pharmaceuticals (Basel) | 2023 | 38139766 | PubTator, text mining | PubMed |
| Combined In Silico and In Vitro Analyses to Assess the Anticancer Potential of Thiazolidinedione-Thiosemicarbazone Hybrid Molecules. | Int J Mol Sci | 2023 | 38139350 | PubTator, text mining | PubMed |
| SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies. | Biomedicines | 2023 | 38137501 | PubTator, text mining | PubMed |
| Cornelia de Lange Syndrome Caused by an Intragenic Heterozygous Deletion in RAD21 Detected through Very-High-Resolution Chromosomal Microarray Analysis. | Genes (Basel) | 2023 | 38137034 | PubTator, text mining | PubMed |
| Efficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders. | Biomolecules | 2023 | 38136568 | PubTator, text mining | PubMed |
| Epigenetic Mechanisms in Hematologic Aging and Premalignant Conditions. | Epigenomes | 2023 | 38131904 | PubTator, text mining | PubMed |
| Brewpitopes: a pipeline to refine B-cell epitope predictions during public health emergencies. | Front Immunol | 2023 | 38124749 | PubTator, text mining | PubMed |
| A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency. | PLoS Pathog | 2023 | 38113273 | PubTator, text mining | PubMed |
| TMP269, a small molecule inhibitor of class IIa HDAC, suppresses RABV replication in vitro. | Front Microbiol | 2023 | 38107853 | PubTator, text mining | PubMed |
| Repurposing fluphenazine as an autophagy modulator for treating liver cancer. | Heliyon | 2023 | 38107270 | PubTator, text mining | PubMed |
| Molecular mechanism and therapeutic potential of HDAC9 in intervertebral disc degeneration. | Cell Mol Biol Lett | 2023 | 38093179 | PubTator, text mining | PubMed |
| Epigenetic Dysregulation in MYCN-Amplified Neuroblastoma. | Int J Mol Sci | 2023 | 38069407 | PubTator, text mining | PubMed |
| HDAC1: An Essential and Conserved Member of the Diverse Zn2+-Dependent HDAC Family Driven by Divergent Selection Pressure. | Int J Mol Sci | 2023 | 38069395 | PubTator, text mining | PubMed |
| The Fundamental Role of Oxime and Oxime Ether Moieties in Improving the Physicochemical and Anticancer Properties of Structurally Diverse Scaffolds. | Int J Mol Sci | 2023 | 38069175 | PubTator, text mining | PubMed |
| Ursolic Acid's Alluring Journey: One Triterpenoid vs. Cancer Hallmarks. | Molecules | 2023 | 38067626 | PubTator, text mining | PubMed |
| Large-scale loss-of-function perturbations reveal a comprehensive epigenetic regulatory network in breast cancer. | Cancer Biol Med | 2023 | 38062748 | PubTator, text mining | PubMed |
| Targeting the E2F1/Rb/HDAC1 axis with the small molecule HR488B effectively inhibits colorectal cancer growth. | Cell Death Dis | 2023 | 38062013 | PubTator, text mining | PubMed |
| 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors. | Sci Rep | 2023 | 38030668 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=12